These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 2029111)

  • 1. Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis. A randomized, double-blind study.
    Jeurissen ME; Boerbooms AM; van de Putte LB; Doesburg WH; Lemmens AM
    Ann Intern Med; 1991 Jun; 114(12):999-1004. PubMed ID: 2029111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis.
    Wendt T; Eidner T; Bräunig E; Hein G
    Eur J Med Res; 1999 Oct; 4(10):442-8. PubMed ID: 10527958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiological and clinical results of longterm treatment of rheumatoid arthritis with methotrexate and azathioprine.
    Kerstens PJ; Boerbooms AM; Jeurissen ME; de Graaf R; Mulder J; van de Putte LB
    J Rheumatol; 2000 May; 27(5):1148-55. PubMed ID: 10813280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate versus azathioprine in the treatment of rheumatoid arthritis. A forty-eight-week randomized, double-blind trial.
    Jeurissen ME; Boerbooms AM; van de Putte LB; Doesburg WH; Mulder J; Rasker JJ; Kruijsen MW; Haverman JF; van Beusekom HJ; Muller WH
    Arthritis Rheum; 1991 Aug; 34(8):961-72. PubMed ID: 1859490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose methotrexate compared with azathioprine in the treatment of rheumatoid arthritis. A twenty-four-week controlled clinical trial.
    Hamdy H; McKendry RJ; Mierins E; Liver JA
    Arthritis Rheum; 1987 Apr; 30(4):361-8. PubMed ID: 3555510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination treatment of rheumatoid arthritis using azathioprine and methotrexate: a 48 week controlled clinical trial.
    Willkens RF; Stablein D
    J Rheumatol Suppl; 1996 Mar; 44():64-8. PubMed ID: 8833056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of azathioprine and methotrexate in rheumatoid arthritis: an open-randomized clinical study].
    Westedt ML; Dijkmans BA; Hermans J
    Rev Rhum Ed Fr; 1994 Oct; 61(9):591-7. PubMed ID: 7858592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double blind placebo controlled trial of pulse treatment with methylprednisolone combined with disease modifying drugs in rheumatoid arthritis.
    Hansen TM; Kryger P; Elling H; Haar D; Kreutzfeldt M; Ingeman-Nielsen MW; Olsson AT; Pedersen C; Rahbek A; Tvede N
    BMJ; 1990 Aug; 301(6746):268-70. PubMed ID: 2202458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial.
    van Everdingen AA; Jacobs JW; Siewertsz Van Reesema DR; Bijlsma JW
    Ann Intern Med; 2002 Jan; 136(1):1-12. PubMed ID: 11777359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial.
    Kremer JM; Genant HK; Moreland LW; Russell AS; Emery P; Abud-Mendoza C; Szechinski J; Li T; Ge Z; Becker JC; Westhovens R
    Ann Intern Med; 2006 Jun; 144(12):865-76. PubMed ID: 16785475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial.
    Smolen JS; Nash P; Durez P; Hall S; Ilivanova E; Irazoque-Palazuelos F; Miranda P; Park MC; Pavelka K; Pedersen R; Szumski A; Hammond C; Koenig AS; Vlahos B
    Lancet; 2013 Mar; 381(9870):918-29. PubMed ID: 23332236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial.
    Bijlsma JWJ; Welsing PMJ; Woodworth TG; Middelink LM; Pethö-Schramm A; Bernasconi C; Borm MEA; Wortel CH; Ter Borg EJ; Jahangier ZN; van der Laan WH; Bruyn GAW; Baudoin P; Wijngaarden S; Vos PAJM; Bos R; Starmans MJF; Griep EN; Griep-Wentink JRM; Allaart CF; Heurkens AHM; Teitsma XM; Tekstra J; Marijnissen ACA; Lafeber FPJ; Jacobs JWG
    Lancet; 2016 Jul; 388(10042):343-355. PubMed ID: 27287832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic resonance imaging for accelerated assessment of drug effect and prediction of subsequent radiographic progression in rheumatoid arthritis: a study of patients receiving combined anakinra and methotrexate treatment.
    Østergaard M; Duer A; Nielsen H; Johansen JS; Narvestad E; Ejbjerg BJ; Baslund B; Møller JM; Thomsen HS; Petersen J
    Ann Rheum Dis; 2005 Oct; 64(10):1503-6. PubMed ID: 15778238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.
    Klareskog L; van der Heijde D; de Jager JP; Gough A; Kalden J; Malaise M; Martín Mola E; Pavelka K; Sany J; Settas L; Wajdula J; Pedersen R; Fatenejad S; Sanda M;
    Lancet; 2004 Feb; 363(9410):675-81. PubMed ID: 15001324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression.
    Atsumi T; Yamamoto K; Takeuchi T; Yamanaka H; Ishiguro N; Tanaka Y; Eguchi K; Watanabe A; Origasa H; Yasuda S; Yamanishi Y; Kita Y; Matsubara T; Iwamoto M; Shoji T; Okada T; van der Heijde D; Miyasaka N; Koike T
    Ann Rheum Dis; 2016 Jan; 75(1):75-83. PubMed ID: 26139005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial.
    Dale J; Stirling A; Zhang R; Purves D; Foley J; Sambrook M; Conaghan PG; van der Heijde D; McConnachie A; McInnes IB; Porter D
    Ann Rheum Dis; 2016 Jun; 75(6):1043-50. PubMed ID: 27026689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group.
    Kirwan JR
    N Engl J Med; 1995 Jul; 333(3):142-6. PubMed ID: 7791815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiographic evidence of disease progression in methotrexate treated and nonmethotrexate disease modifying antirheumatic drug treated rheumatoid arthritis patients: a meta-analysis.
    Alarcón GS; López-Méndez A; Walter J; Boerbooms AM; Russell AS; Furst DE; Rau R; Drosos AA; Bartolucci AA
    J Rheumatol; 1992 Dec; 19(12):1868-73. PubMed ID: 1345138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative controlled trial of low-dose weekly methotrexate versus azathioprine in rheumatoid arthritis: 3-year prospective study.
    Arnold MH; O'Callaghan J; McCredie M; Beller EM; Kelly DE; Brooks PM
    Br J Rheumatol; 1990 Apr; 29(2):120-5. PubMed ID: 2182169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient retention and hand-wrist radiograph progression of rheumatoid arthritis during a 3-year prospective study that prohibited disease modifying antirheumatic drugs.
    Paulus HE; Di Primeo D; Sharp JT; Genant HK; Weissman BN; Weisman MH; Sanda M;
    J Rheumatol; 2004 Mar; 31(3):470-81. PubMed ID: 14994390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.